Finance

Beta
Lists
VKTX:NASDAQ
Viking Therapeutics Inc
$28.21
-5.27%
(-1.57) 1D
Jun 5, 3:32:54 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VKTX...
Open
$29.57
High
$29.81
Low
$28.04
Mkt. cap
3.27B
Avg. vol.
2.15M
Volume
1.94M
52-wk high
$43.15
52-wk low
$22.96
EPS
-$4.15
Beta
0.69
Shares outstanding
116.11M
No. of employees
59
Open
$29.57
High
$29.81
Low
$28.04
Mkt. cap
3.27B
Avg. vol.
2.15M
Volume
1.94M
52-wk high
$43.15
52-wk low
$22.96
EPS
-$4.15
Beta
0.69
Shares outstanding
116.11M
No. of employees
59
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to VKTX in the past 3 months
Strong Buy
Buy
11
Hold
0
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for VKTX in the last 3 months.
Highest
Current $28.21
$125.00 (+343.11%)
Average
$93.70 (+232.15%)
Lowest
$70.00 (+148.14%)
News stories
From sources across the web
About Viking Therapeutics Inc
CEOBrian Lian
Employees59
Founded2012
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
60.15M
89.95M
153.46M
150.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.42M
8.61M
11.28M
13.98M
Operating expense
74.57M
98.56M
164.74M
164.12M
Total operating expenses
74.57M
98.56M
164.74M
164.12M
Operating income
-74.57M
-98.56M
-164.74M
-164.12M
Other non operating income
-
-
-
-
EBT including unusual items
-65.56M
-90.79M
-157.66M
-158.32M
EBT excluding unusual items
-65.56M
-90.80M
-157.70M
-158.32M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-65.56M
-90.79M
-157.66M
-158.32M
Net profit margin
-
-
-
-
Earnings per share
-0.58
-0.81
-1.38
-1.37
Interest and investment income
9.03M
7.77M
7.04M
5.80M
Interest expense
-24.00K
-8.00K
-
-
Net interest expenses
9.01M
7.76M
7.04M
5.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more